Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
Кафедра психиатрии, психосоматики и психотерапии Университета г. Регенсбурга, Германия
Список исп. литературыСкрыть список 1. Monteleone P, Maj M. The circadian basis of mood disorders: Recent developments and treatment implications. Eur Neuropsychopharmacology 2008; 18: 701–11. 2. Schulz P, Steimer T. Neurobiology of circadian systems. CNS Drugs. 2009; 23 (suppl2): 3–13. 3. Buijs MR, Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Wat Rev Neurosci 2001; 2: 521–6. 4. Tigges M, Marquez-Lago TT, Stelling J, Fussenegger M. A tunable synthetic mammalian oscillator. Nature 2009; 457: 309–12. 5. Franken P, Dijk DJ. Circadian clock genes and sleep homeostasis. Eur J Neurosci 2009; 29: 1820–9. 6. Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol 2008; 6: 367–78. 7. Froy O. Metabolism and circadian rhythms-implications for obesity. Endocr Rev 2009, October 23. 8. Ruger M, Scheer FA. Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord 2009. 9. Gerstner JR, Lyons LC, Wright KP Jr, et al. Cycling behavior and memory formation. J Neurosci 2009; 29: 12824–30. 10. Reilly T, Waterhouse J. Sports performance: is there evidence that the body clock plays a role? EurJAppi Physiol 2009; 106: 321–32. 11. Yamaguchi S, Isejima H, Matsuo T et al. Synchronization of cellular clocks in the suprachiasmatic nucleus. Science 2003; 302: 1408–12. 12. Gorwood P. Depression and circadian rhythm disturbances. Medicographia 2007; 29: 22–7. 13. Basner M, Fomberstein KM, Razavi FM et al. America, time use survey: sleep time and its relationship to waking activities. Sleep 2007; 30: 1085–95. 14. National Sleep Foundation USA. http: //www.sleepfoundation.org. Accessed October 22, 2009. 15. Hajak G. Clocks drive human behavior: disturbance of clock function may cause depression. Editorial. Reference in Psychiatry. In press. 16. Benca R, Duncan MJ, Frank E et al. Biological rhythms, higher brain function, and behavior: gaps, opportunities, and challenges. Brain Res Rev 2009. Epub ahead of print. 17. Lamont EW, Legault-Coutu D, Cermakian N, Boivln DB. The role of circadian clock genes in mental disorders. Dialogues Clin Neurosci 2007; 9: 333–42. 18. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008; 165: 820–9. 19. McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007; 114: 222–32. 20. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol 2008; 23: 571–85. 21. Mendlewicz J. Circadian Rhythms and Depression. Current Understanding and New Therapeutic Perspectives. Paris, France: Wolters Kluwer Health; 2008. 22. Souetre E, Salvati E, Belugou JL et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res 1989; 28: 263–78. 23. Souetre E, Salvati E, Wehr TA et al. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during de¬pression and during remission and in normal control subjects. Am J Psychiatry 1988; 145: 1133–7. 24. Parry BL, Mendelson WB, Duncan WC et al. Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res 1989; 30: 285–303. 25. Antonijevic I. HPA axis and sleep: identifying subtypes of major depression. Stress.2008; 11: 15–27. 26. Tichomirowa MA, Keck ME, Schneider HJ et al. Endocrine disturbances in depression. J Endocrinol Invest. 2005; 28: 89–99. 27. McKay MS, Zakzanis KK. The impact of treatment on HPA axis activity in unipolar major depression. J Psychiatr Res 2009. Epub ahead of print. 28. Lopez-Duran NL, Kovacs M, George CJ. Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis. Psychoneuroendccrinclogy 2009; 34: 1272–83. 29. Van Cauter E, Leproult R, Kupfer DJ. Effects of gender and age on the levels and rhythmicity of plasma Cortisol. J Clin Endocrinol Metab. 1996; 81: 2468–73. 30. Srinivasan V, Smits M, Spence W et al. Melatonin in mood disorders. World J Biol Psychiatry. 2006; 7: 138–51. 31. Carvalho LA, Gorenstein C, Moreno RA, Markus RR. Melatonin levels in drug-free patients with major depression from the southern hemisphere. Psycho-neuroendocrinology 2006; 31: 761–8. 32. Brunello N, Armitage R, Feinberg I et al. Depression and sleep disorders: clinical relevance, economic burden and pharmacological treatment. Neuropsy-chobiology 2000; 42: 107–19. 33. Riemann D. Insomnia and comorbid psychiatric disorders. Sleep Med.2007; 8 (suppl 4): S15–S20. 34. Franzen PL, Buysse DJ. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci 2008; 10: 473–81. 35. Mendlewicz J. Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 2009; 23 (suppl 2): 15–26. 36. Bunney JN, Potkin SG. Circadian abnormalities, molecular clock genes and chronobiological treatments in depression. Br Med Bull. 2008; 86: 23–32. 37. Srinivasan V, Pandi-Perumal SR, Trakht I et al. Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res. 2009; 165: 201–14. 38. Chellappa SL, Schroder C, Cajochen C. Chronobiology, excessive daytime sleepiness and depression: is there a link? Sleep Med 2009; 10: 505–14. 39. Engel GL. The need for a new medical model: a challenge for biomedicine. Science 1977; 196: 129–36. 40. Wirz-Justice A. Diurnal variation of depressive symptoms. Dialogues Clin Neurosci 2008; 10: 337–43. 41. Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev 2007; 11: 509–22. 42. Hajak G, Popp R. Circadian rhythm resynchronisation in treatment of depression. In: Mendlewicz J (ed). Orcadian Rhythms and Depression. Current Understanding and New Therapeutic Perspectives. Paris, France: Wolters Kluwer Health 2008: 77–95. 43. Eichhammer P, Kharraz A, Wiegand R et al. Sleep deprivation in depression: stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. Life Sci 2002; 70: 1–9. 44. Hajak G. Agomelatine and sleep-wake-rhythm in depression. Psychopharma-kotherapie 2009; (suppl 19): 15–20. 45. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erb alpha is a critical lithium-sensitive component of the circadian clock. Science 2006; 311: 1002–5. 46. Tan ZL, Bao AM, Zhao GQ et al. Effect of fluoxetine on circadian rhythm of melatonin in patients with major depressive disorder. Neuro Endocrinol lett 2007; 28: 28–32. 47. Kennedy SH. Agomelatine: an antidepressant with a novel mechanism of action. Future Neurol 2007; 2: 145–51. 48. San L, Arranz B. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system. Eur Psychiatry 2008; 23: 396–402. 49. Delagrange R Boutin JA. Therapeutic potential of melatonin ligands. Chronobioi Int 2006; 23: 413–8. 50. Racagni G, Riva MA, Popoli M. The interaction between the internal clock and antidepressant efficacy. Int Clin Psychopharmacol 2007; 22 (suppl. 2): S9–S14. 51. Krauchi K. The thermophysiological cascade leading to sleep initiation in relation to phase of entrainment. Sleep Med Rev 2007; 11: 439–51. 52. Quera Salva MA, Vanier B, Laredo J et al. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol 2007; 10: 691–6. 53. Lemoine P, Guilleminault C, Alvarez E. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J Clin Psychiatry 2007; 68: 1723–32. 54. Wirz-Justice A. Chronobiology and psychiatry. Sleep Med Rev 2007; 11: 423–7.